Abstract:Depression is one of the complications in patients with polycystic ovary syndrome (PCOS) that leads to considerable mental health. Accumulating evidence suggests that human gut microbiomes are associated with the progression of PCOS and depression. However, whether microbiota influences depression development in PCOS patients is still uncharacterized. In this study, we employed metagenomic sequencing and transcriptome sequencing (RNA-seq) to profile the composition of the fecal microbiota and gene expression of peripheral blood mononuclear cells in depressed women with PCOS (PCOS-DP, n = 27) in comparison to mentally healthy women with PCOS (PCOS, n = 18) and compared with healthy control (HC, n = 27) and patients with major depressive disorder (MDD, n = 29). Gut microbiota assessment revealed distinct patterns in the relative abundance in the PCOS-DP compared to HC, MDD, and PCOS groups. Several gut microbes exhibited uniquely and significantly higher abundance in the PCOS-DP compared to PCOS patients, inducing EC Ruminococcus torques, Coprococcus comes, Megasphaera elsdenii, Acidaminococcus intestini, and Barnesiella viscericola. Bacteroides eggerthii was a potential gut microbial biomarker for the PCOS-DP. RNA-seq profiling identified that 35 and 37 genes were significantly elevated and downregulated in the PCOS-DP, respectively. The enhanced differential expressed genes (DEGs) in the PCOS-DP were enriched in pathways involved in signal transduction and endocrine and metabolic diseases, whereas several lipid metabolism pathways were downregulated. Intriguingly, genes correlated with the gut microbiota were found to be significantly enriched in pathways of neurodegenerative diseases and the immune system, suggesting that changes in the microbiota may have a systemic impact on the expression of neurodegenerative diseases and immune genes. Gut microbe-related DEGs of CREB3L3 and CCDC173 were possible molecular biomarkers and therapeutic targets of women with PCOS-DP. Our multi-omics data indicate shifts in the gut microbiome and host gene regulation in PCOS patients with depression, which is of possible etiological and diagnostic importance.

Exploring the Hypothetical Role of Species in Depression Progression: Insights from Metagenomic Analysis

Variations in Gut Microbiota and Fecal Metabolic Phenotype Associated with Depression by 16S Rrna Gene Sequencing and LC/MS-based Metabolomics.

A case-control study on the abundance, species and gene functional pathway of gut microbiota in patients with depression

Deciphering the Gut Microbiome's Influence on Depression: A Community-Level Constraint-Based Metabolic modelling Approach

Characteristics of gut microbiota and metabolic phenotype in patients with major depressive disorder based on multi-omics analysis

Altered gut bacterial-fungal interkingdom networks in children and adolescents with depression

Multiomics Study of Gut Bacteria and Host Metabolism in Irritable Bowel Syndrome and Depression Patients

Core Antibiotic Resistance Genes Mediate Gut Microbiota to Intervene in the Treatment of Major Depressive Disorder

A pilot exploration of multi-omics research of gut microbiome in major depressive disorders

Integrated multi-omics analysis reveals gut microbiota dysbiosis and systemic disturbance in major depressive disorder

Microbiota Alters and Its Correlation with Molecular Regulation Underlying Depression in PCOS Patients

Comparative metaproteomics analysis shows altered fecal microbiota signatures in patients with major depressive disorder.

Bacteroides Species Differentially Modulate Depression-Like Behavior Via Gut-Brain Metabolic Signaling.

Depression-associated gut microbes, metabolites and clinical trials

Gut Microbiome Remodeling Induces Depressive-Like Behaviors Through A Pathway Mediated by the Host'S Metabolism

Multi-cohort analysis of depression-associated gut bacteria sheds insight on bacterial biomarkers across populations

Associations Between Disordered Microbial Metabolites and Changes of Neurotransmitters in Depressed Mice.

Multi-omics data reveals the disturbance of glycerophospholipid metabolism caused by disordered gut microbiota in depressed mice

Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism

Exploration of the relationship between gut microbiota and fecal microRNAs in patients with major depressive disorder

Comparative analysis of gut microbiota and fecal metabolome features among multiple depressive animal models